|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current assets | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total current assets | |||||||
| Investments Held in Trust Account | |||||||
| Total assets | |||||||
| LIABILITIES, REDEEMABLE CLASS A COMMON STOCK AND STOCKHOLDER'S DEFICIT | |||||||
| LIABILITIES | |||||||
| Current liabilities | |||||||
| Accrued expenses | |||||||
| Accrued offering costs | |||||||
| Franchise tax payable | |||||||
| Income tax payable | |||||||
| Interest payable | |||||||
| Note payable | |||||||
| Total current liabilities | |||||||
| Non-current liabilities | |||||||
| Deferred underwriter fee payable | |||||||
| Warrant liability | |||||||
| Note payable | |||||||
| Total non-current liabilities | |||||||
| Total liabilities | |||||||
| Redeemable Class A Common stock | |||||||
| Redeemable Class A common stock, $0.0001 par value; 100,000,000 shares authorized, 289,195 and 15,000,000 shares issued and outstanding, respectively, subject to possible redemption, at redemption value | |||||||
| STOCKHOLDER'S DEFICIT | |||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | |||||||
| Common stock value | |||||||
| Common Class A | |||||||
| Common Class B | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Common Class A | |||||||
| Common Class B | |||||||
| Total Stockholder's Deficit | |||||||
| Total Liabilities, Redeemable Class A Common Stock and Stockholder's Deficit |
Loading...